Deutsche Bank
NVLN

Deutsche Bank’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Deutsche Bank’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-19,078
Closed -$70K – 5684
2018
Q2 		$70K Sell
19,078
-2,904
-13% -$11.7K ﹤0.01% 4674
2018
Q1 		$76K Sell
21,982
-14,493
-40% -$61.4K ﹤0.01% 4618
2017
Q4 		$112K Buy
36,475
+16,521
+83% +$79.4K ﹤0.01% 4225
2017
Q3 		$139K Sell
19,954
-60,280
-75% -$483K ﹤0.01% 4044
2017
Q2 		$740K Sell
80,234
-92,688
-54% -$893K ﹤0.01% 3214
2017
Q1 		$1.86M Buy
172,922
+76,503
+79% +$782K ﹤0.01% 2289
2016
Q4 		$811K Buy
+96,419
New +$854K ﹤0.01% 2846

Other funds holding NVLN

EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $38.5M AUM 24.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return